
Alexander Vos
Focus: Europe
C-suite Healthcare Executive
Career Highlights
Alexander Vos is a seasoned leader in the biotech industry with over 25 years of experience. As the Managing Director of Biotech Mountains BV, he brings a wealth of knowledge and expertise to the table. Vos began his career at McKinsey & Co. in the pharmaceutical practice before moving to Genzyme Therapeutics Europe, where he held several executive positions, including global responsibility for the Genzyme/Pharming joint venture to develop enzyme replacement therapy for Pompe’s Disease. His leadership skills were further demonstrated during his tenure as CEO of MediService AG, a leading specialty pharmacy service company in Europe, which he successfully sold to Galenica AG.
Vos has also held significant roles in other prominent biotech companies. He served as a member of the management board, deputy-CEO, and COO of PAION AG, a publicly listed, clinical-stage biopharma company. As CEO of PharmaCell BV, he transformed the company into the leading European contract manufacturing organization (CMO) for cell and gene therapy, culminating in its sale to Lonza in May 2017, creating a successful exit for investors. His extensive experience in strategy development, operations management, and corporate partnerships has made him a key figure in the biotech industry, driving innovation and growth across multiple organizations.
Education
-
MS, Pharmacy and Pharmacology: University of Amsterdam
-
MBA: Stanford University